Kókai Eszter, Halász Judit, Dancsó András, Nagy József, Simig Gyula, Volk Balázs
Directorate of Drug Substance Development, Egis Pharmaceuticals Plc., P.O. Box 100, 1475 Budapest, Hungary.
Department of Organic Chemistry and Technology, Budapest University of Technology and Economics, P.O. Box 91, 1521 Budapest, Hungary.
Molecules. 2017 May 19;22(5):846. doi: 10.3390/molecules22050846.
The chemistry of the 5,7-dihydro-6-pyrrolo[2,3-]pyrimidin-6-one (1,3-diazaoxindole) compound family, possessing a drug-like scaffold, is unexplored. In this study, the alkylation reactions of (7)-unsubstituted 5-isopropyl-1,3-diazaoxindoles bearing various substituents at the (2) position have been investigated. The starting compounds were synthesized from the (5)-unsubstituted parent compounds by condensation with acetone and subsequent catalytic reduction of the 5-isopropylidene moiety. Alkylation of the thus obtained 5-isopropyl derivatives with methyl iodide or benzyl bromide in the presence of a large excess of sodium hydroxide led to 5,7-disubstituted derivatives. Use of butyllithium as the base rendered alkylation in the (5) position possible with reasonable selectivity, without affecting the (7) atom. During the study on the alkylation reactions, some interesting by-products were also isolated and characterized.
具有类药物骨架的5,7-二氢-6-吡咯并[2,3 - ]嘧啶-6-酮(1,3-二氮杂吲哚)化合物家族的化学性质尚未被探索。在本研究中,对在(2)位带有各种取代基的(7)-未取代的5-异丙基-1,3-二氮杂吲哚的烷基化反应进行了研究。起始化合物由(5)-未取代的母体化合物与丙酮缩合,随后对5-异亚丙基部分进行催化还原合成。在大量过量氢氧化钠存在下,用碘甲烷或苄基溴对由此得到的5-异丙基衍生物进行烷基化反应,得到5,7-二取代衍生物。使用丁基锂作为碱使得在(5)位进行烷基化反应具有合理的选择性成为可能,且不会影响(7)位原子。在烷基化反应的研究过程中,还分离并表征了一些有趣的副产物。